Form 8-K - Current report:
SEC Accession No. 0001193125-25-050448
Filing Date
2025-03-10
Accepted
2025-03-10 09:01:07
Documents
13
Period of Report
2025-03-07
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K d890669d8k.htm   iXBRL 8-K 26758
  Complete submission text file 0001193125-25-050448.txt   149050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alec-20250307.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20250307_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20250307_pre.xml EX-101.PRE 11253
15 EXTRACTED XBRL INSTANCE DOCUMENT d890669d8k_htm.xml XML 3614
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 25722350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)